Insider Transactions in Q1 2023 at Alteryx, Inc. (AYX)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 08
2023
|
Eileen Schloss Director |
SELL
Open market or private sale
|
Direct |
4,500
-40.12%
|
$292,500
$65.47 P/Share
|
|
Mar 07
2023
|
Suresh Vittal Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,726
+18.24%
|
-
|
|
Mar 07
2023
|
Kevin Rubin Interim CEO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
43,726
+19.22%
|
-
|
|
Mar 07
2023
|
Christopher M Lal CLO & Corp. Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
23,013
+16.63%
|
-
|
|
Mar 07
2023
|
Paula Hansen President & CRO |
BUY
Grant, award, or other acquisition
|
Direct |
51,780
+23.41%
|
-
|
|
Mar 07
2023
|
Mark Anderson Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
115,068
+25.08%
|
-
|
|
Mar 07
2023
|
Chris Natali Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,506
+20.94%
|
-
|
|
Mar 01
2023
|
Kevin Rubin Interim CEO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,814
-7.17%
|
$702,910
$65.34 P/Share
|
|
Mar 01
2023
|
Mark Anderson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,896
-6.88%
|
$1,098,240
$65.34 P/Share
|
|
Mar 01
2023
|
Suresh Vittal Chief Product Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,627
-3.56%
|
$365,755
$65.34 P/Share
|
|
Mar 01
2023
|
Christopher M Lal CLO & Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,740
-4.88%
|
$308,100
$65.34 P/Share
|
|
Mar 01
2023
|
Paula Hansen President & CRO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,562
-2.94%
|
$231,530
$65.34 P/Share
|
|
Mar 01
2023
|
Chris Natali Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,265
-11.78%
|
$277,225
$65.34 P/Share
|
|
Feb 20
2023
|
Kevin Rubin Interim CEO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
17,326
+10.3%
|
$1,160,842
$67.01 P/Share
|
|
Feb 20
2023
|
Suresh Vittal Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,326
+9.89%
|
$1,160,842
$67.01 P/Share
|
|
Feb 20
2023
|
Christopher M Lal CLO & Corp. Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
9,240
+8.69%
|
$619,080
$67.01 P/Share
|
|
Feb 20
2023
|
Paula Hansen President & CRO |
BUY
Grant, award, or other acquisition
|
Direct |
17,326
+12.51%
|
$1,160,842
$67.01 P/Share
|
|
Jan 01
2023
|
Dean Stoecker Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,379
-2.9%
|
$118,950
$50.67 P/Share
|
|
Jan 01
2023
|
Christopher M Lal CLO & Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
969
-1.1%
|
$48,450
$50.67 P/Share
|
|
Jan 01
2023
|
Kevin Rubin Interim CEO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,323
-0.98%
|
$66,150
$50.67 P/Share
|